SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-13-404152
Filing Date
2013-10-21
Accepted
2013-10-18 17:57:08
Documents
6
Period of Report
2013-08-05
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d614346d8ka.htm 8-K/A 22210
2 EX-23.1 d614346dex231.htm EX-23.1 1650
3 EX-23.2 d614346dex232.htm EX-23.2 4996
4 EX-99.3 d614346dex993.htm EX-99.3 525012
5 EX-99.4 d614346dex994.htm EX-99.4 465416
6 GRAPHIC g614346g32r67.jpg GRAPHIC 2748
  Complete submission text file 0001193125-13-404152.txt   1024511
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-14956 | Film No.: 131160238
SIC: 2834 Pharmaceutical Preparations